BIO-TECH PROSTHETICS & ORTHOTICS INC

BIO-TECH PROSTHETICS & ORTHOTICS INC specializes in the design, fabrication, and custom fitting of advanced prosthetic and orthotic devices for government beneficiaries. Leveraging precision manufacturing techniques and biomechanical engineering principles, the company delivers patient-specific solutions that enhance mobility, restore function, and support long-term rehabilitation outcomes. Their technical expertise includes 3D scanning and modeling, carbon fiber composite fabrication, microprocessor-controlled joint systems, and socket fit optimization using anthropometric data. The firm’s differentiation lies in its hands-on clinical collaboration model, ensuring devices are tailored to individual gait patterns, residual limb morphology, and activity-level requirements—critical for veterans and active-duty personnel with complex mobility impairments. Award history is not available to confirm specific agency engagements, but given the nature of their NAICS classification and industry focus, their work is inherently aligned with Department of Defense and Veterans Health Administration programs that support wounded service members and veterans requiring mobility assistance. Their services likely support clinical rehabilitation pipelines within military medical centers and VA prosthetics clinics, where customized orthotic and prosthetic care is a core component of post-injury recovery. The company operates under NAICS 339113, which encompasses the manufacture of prosthetic and orthotic devices. In practice, this means they are a clinical manufacturing entity that bridges medical need with engineered solution delivery—serving the rehabilitative medicine market with high-acuity, low-volume, high-complexity devices. Their positioning is that of a specialized medical device fabricator focused on functional restoration rather than mass production. As a 2L entity based in Greensboro, NC, BIO-TECH PROSTHETICS & ORTHOTICS INC is a small, locally rooted business with no federal certifications on record. Their government market presence is defined by direct clinical delivery capabilities rather than broad-scale contract vehicles, positioning them as a niche provider within the federal prosthetics supply chain.